歐普康視 (300595.SZ)

15.68 -0.30 (-1.88%) 收市：03:04PM CST

歐普康視

No. 4899 Wangjiang West Road
High-tech Zone
Hefei 230088
China
86 55 1629 52208
https://www.orthok.cn

版塊: Healthcare
行業: Medical Instruments & Supplies
全職員工: 3,229

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Yuequn Tao	GM & Chairman	無	無	1960
Mr. Lizhi Wei	CFO & Non-Independent Director	無	無	1982
Ms. Zhiying Fu	Deputy GM & Director	無	無	1983
Mr. Zhe Zhu	Deputy General Manager	無	無	1965
Ms. Xianmei Shi	Deputy GM, Company Secretary & Non-Independent Director	無	無	1974
Mr. Yongzhan Xiao	Deputy General Manager	無	無	1970

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Autek China Inc. provides eye health and myopia prevention, and control technology and services in China. It operates through Ophthalmology and Optometry Medical Equipment; and Ophthalmology Service segments. The company offers rigid contact lenses including orthokeratology lenses and supporting care products. It engages in the provision of technical services, development, consultation, exchange, transfer and promotion activities; and sale of second-class medical devices, lighting appliance and electronic products, optical instrument disinfectants, glasses, and daily necessities. In addition, the company offers health consultation services; sale of prepackaged foods; and engages production, wholesale, and retailing of drugs, as well as provides inspection and testing services. Autek China Inc. was founded in 2000 and is headquartered in Hefei, China.

公司管治

截至 2024年6月1日 止，歐普康視 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中：5；董事會：10；股東權利：2；現金賠償：2。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。